These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 23275532)
1. Mycobacterium fluoroquinolone resistance protein B, a novel small GTPase, is involved in the regulation of DNA gyrase and drug resistance. Tao J; Han J; Wu H; Hu X; Deng J; Fleming J; Maxwell A; Bi L; Mi K Nucleic Acids Res; 2013 Feb; 41(4):2370-81. PubMed ID: 23275532 [TBL] [Abstract][Full Text] [Related]
2. Mycobacterium Fluoroquinolone Resistance Protein D (MfpD), a GTPase-Activating Protein of GTPase MfpB, Is Involved in Fluoroquinolones Potency. Huang Y; Yan S; Li Y; Ai X; Yu X; Ge Y; Lv X; Fan L; Xie J Microbiol Spectr; 2022 Dec; 10(6):e0209822. PubMed ID: 36453945 [TBL] [Abstract][Full Text] [Related]
4. Mycobacterium smegmatis MfpC is a GEF that regulates mfpA translationally to alter the fluoroquinolone efficacy. Huang Y; Shen Q; Xu H; Huang L; Xiang S; Li P; Fan L; Xie J Commun Biol; 2024 Aug; 7(1):1035. PubMed ID: 39179666 [TBL] [Abstract][Full Text] [Related]
5. The pentapeptide-repeat protein, MfpA, interacts with mycobacterial DNA gyrase as a DNA T-segment mimic. Feng L; Mundy JEA; Stevenson CEM; Mitchenall LA; Lawson DM; Mi K; Maxwell A Proc Natl Acad Sci U S A; 2021 Mar; 118(11):. PubMed ID: 33836580 [TBL] [Abstract][Full Text] [Related]
6. A fluoroquinolone resistance protein from Mycobacterium tuberculosis that mimics DNA. Hegde SS; Vetting MW; Roderick SL; Mitchenall LA; Maxwell A; Takiff HE; Blanchard JS Science; 2005 Jun; 308(5727):1480-3. PubMed ID: 15933203 [TBL] [Abstract][Full Text] [Related]
7. Mechanisms of fluoroquinolone resistance in Mycobacterium tuberculosis. Zhang YJ; Li XJ; Mi KX Yi Chuan; 2016 Oct; 38(10):918-927. PubMed ID: 27806933 [TBL] [Abstract][Full Text] [Related]
8. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding. Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635 [TBL] [Abstract][Full Text] [Related]
9. Enhancement of fluoroquinolone activity by C-8 halogen and methoxy moieties: action against a gyrase resistance mutant of Mycobacterium smegmatis and a gyrase-topoisomerase IV double mutant of Staphylococcus aureus. Lu T; Zhao X; Li X; Drlica-Wagner A; Wang JY; Domagala J; Drlica K Antimicrob Agents Chemother; 2001 Oct; 45(10):2703-9. PubMed ID: 11557458 [TBL] [Abstract][Full Text] [Related]
10. Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpA. Montero C; Mateu G; Rodriguez R; Takiff H Antimicrob Agents Chemother; 2001 Dec; 45(12):3387-92. PubMed ID: 11709313 [TBL] [Abstract][Full Text] [Related]
11. A rapid and non-pathogenic assay for association of Mycobacterium tuberculosis gyrBA mutations and fluoroquinolone resistance using recombinant Mycobacterium smegmatis. Yoshida M; Nakata N; Miyamoto Y; Fukano H; Ato M; Hoshino Y FEMS Microbiol Lett; 2018 Dec; 365(23):. PubMed ID: 30418577 [TBL] [Abstract][Full Text] [Related]
12. Effect of different classes of inhibitors on DNA gyrase from Mycobacterium smegmatis. Chatterji M; Unniraman S; Mahadevan S; Nagaraja V J Antimicrob Chemother; 2001 Oct; 48(4):479-85. PubMed ID: 11581225 [TBL] [Abstract][Full Text] [Related]
13. Fluoroquinolone and quinazolinedione activities against wild-type and gyrase mutant strains of Mycobacterium smegmatis. Malik M; Marks KR; Mustaev A; Zhao X; Chavda K; Kerns RJ; Drlica K Antimicrob Agents Chemother; 2011 May; 55(5):2335-43. PubMed ID: 21383100 [TBL] [Abstract][Full Text] [Related]
14. Fluoroquinolone interactions with Mycobacterium tuberculosis gyrase: Enhancing drug activity against wild-type and resistant gyrase. Aldred KJ; Blower TR; Kerns RJ; Berger JM; Osheroff N Proc Natl Acad Sci U S A; 2016 Feb; 113(7):E839-46. PubMed ID: 26792518 [TBL] [Abstract][Full Text] [Related]
15. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis. Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828 [TBL] [Abstract][Full Text] [Related]
16. WQ-3810: A new fluoroquinolone with a high potential against fluoroquinolone-resistant Mycobacterium tuberculosis. Ouchi Y; Mukai T; Koide K; Yamaguchi T; Park JH; Kim H; Yokoyama K; Tamaru A; Gordon SV; Nakajima C; Suzuki Y Tuberculosis (Edinb); 2020 Jan; 120():101891. PubMed ID: 31778929 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of DNA gyrase activity by Mycobacterium smegmatis MurI. Sengupta S; Nagaraja V FEMS Microbiol Lett; 2008 Feb; 279(1):40-7. PubMed ID: 18177305 [TBL] [Abstract][Full Text] [Related]
18. Biochemistry. Protein that mimics DNA helps tuberculosis bacteria resist antibiotics. Ferber D Science; 2005 Jun; 308(5727):1393. PubMed ID: 15933168 [No Abstract] [Full Text] [Related]
19. Emergence of fluoroquinolone-resistant Propionibacterium acnes caused by amino acid substitutions of DNA gyrase but not DNA topoisomerase IV. Nakase K; Sakuma Y; Nakaminami H; Noguchi N Anaerobe; 2016 Dec; 42():166-171. PubMed ID: 27793740 [TBL] [Abstract][Full Text] [Related]
20. A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism. Manjunatha UH; Maxwell A; Nagaraja V Nucleic Acids Res; 2005; 33(10):3085-94. PubMed ID: 15930158 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]